Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

16.45

-0.50 (-2.95%)

At close: Mar 9, 2026, 4:00 PM EDT

16.48

+0.03 (0.18%)

After-hours: Mar 9, 2026, 7:48 PM EDT

Tango Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Mar '26 Mar 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2019
Market Capitalization	2,347	1,193	332	1,010	639	958	Upgrade
Market Cap Growth	825.91%	259.50%	-67.13%	57.94%	-33.25%	-	Upgrade
Enterprise Value	2,038	1,075	76	689	287	461	Upgrade
Last Close Price	16.45	8.86	3.09	9.90	7.25	10.94	Upgrade
PS Ratio	37.63	19.13	7.89	27.64	25.72	25.86	Upgrade
PB Ratio	6.46	3.45	1.66	3.99	2.56	2.78	Upgrade
P/TBV Ratio	6.78	3.45	1.66	3.99	2.56	2.78	Upgrade
EV/Sales Ratio	32.66	17.24	1.81	18.87	11.53	12.45	Upgrade
Debt / Equity Ratio	0.10	0.10	0.18	0.15	0.17	0.00	Upgrade
Net Debt / Equity Ratio	-0.89	-0.89	-1.11	-1.18	-1.30	-1.40	Upgrade
Net Debt / EBITDA Ratio	2.84	2.84	1.55	2.67	2.97	8.44	Upgrade
Net Debt / FCF Ratio	2.21	2.21	1.67	2.49	2.78	7.88	Upgrade
Asset Turnover	0.17	0.17	0.12	0.09	0.05	0.11	Upgrade
Quick Ratio	15.83	15.83	6.76	7.33	6.63	11.98	Upgrade
Current Ratio	16.32	16.32	6.98	7.54	6.76	12.10	Upgrade
Return on Equity (ROE)	-37.23%	-37.23%	-57.58%	-40.49%	-36.41%	-30.38%	Upgrade
Return on Assets (ROA)	-19.45%	-19.45%	-25.31%	-17.01%	-14.82%	-10.28%	Upgrade
Return on Capital Employed (ROCE)	-29.50%	-29.50%	-52.30%	-32.00%	-29.20%	-12.70%	Upgrade
Earnings Yield	-4.33%	-8.51%	-39.26%	-10.08%	-16.92%	-6.08%	Upgrade
FCF Yield	-5.96%	-11.73%	-39.85%	-11.84%	-18.27%	-6.41%	Upgrade
Buyback Yield / Dilution	-6.35%	-6.35%	-15.50%	-7.69%	-41.40%	-94.50%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.